nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2D6—Parkinson's disease	0.952	1	CbGaD
Flecainide—Mefloquine—ADORA2A—Parkinson's disease	0.0127	0.722	CrCbGaD
Flecainide—Mefloquine—CYP2D6—Parkinson's disease	0.00285	0.162	CrCbGaD
Flecainide—Mefloquine—ABCB1—Parkinson's disease	0.00204	0.116	CrCbGaD
Flecainide—SCN4A—L1CAM interactions—DLG1—Parkinson's disease	0.00132	0.0428	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.000974	0.0315	CbGpPWpGaD
Flecainide—SCN5A—L1CAM interactions—DLG1—Parkinson's disease	0.000896	0.029	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—Parkinson's disease	0.000804	0.026	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—NRTN—Parkinson's disease	0.000801	0.0259	CbGpPWpGaD
Flecainide—CYP2C9—CYP2E1 reactions—CYP2D6—Parkinson's disease	0.000742	0.024	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.000738	0.0239	CbGpPWpGaD
Flecainide—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00069	0.0223	CbGpPWpGaD
Flecainide—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000685	0.0221	CbGpPWpGaD
Flecainide—CYP2C9—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000679	0.022	CbGpPWpGaD
Flecainide—SCN4A—L1CAM interactions—HSPA8—Parkinson's disease	0.000618	0.02	CbGpPWpGaD
Flecainide—SCN4A—L1CAM interactions—DLG4—Parkinson's disease	0.00058	0.0188	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—NRTN—Parkinson's disease	0.000571	0.0185	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—NRTN—Parkinson's disease	0.000543	0.0176	CbGpPWpGaD
Flecainide—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000507	0.0164	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—IGF2—Parkinson's disease	0.000502	0.0162	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—DLG1—Parkinson's disease	0.0005	0.0162	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.000461	0.0149	CbGpPWpGaD
Flecainide—CYP2C9—Xenobiotics—CYP2D6—Parkinson's disease	0.00046	0.0149	CbGpPWpGaD
Flecainide—CYP2C9—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000443	0.0143	CbGpPWpGaD
Flecainide—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000425	0.0137	CbGpPWpGaD
Flecainide—CYP2C9—Xenobiotics—CYP2E1—Parkinson's disease	0.000421	0.0136	CbGpPWpGaD
Flecainide—SCN5A—L1CAM interactions—HSPA8—Parkinson's disease	0.000419	0.0135	CbGpPWpGaD
Flecainide—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000408	0.0132	CbGpPWpGaD
Flecainide—CYP2C9—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000405	0.0131	CbGpPWpGaD
Flecainide—SCN5A—L1CAM interactions—DLG4—Parkinson's disease	0.000393	0.0127	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—GDNF—Parkinson's disease	0.000391	0.0126	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—NRTN—Parkinson's disease	0.000387	0.0125	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—DLG1—Parkinson's disease	0.000357	0.0115	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—DLG1—Parkinson's disease	0.000339	0.011	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—INS—Parkinson's disease	0.000333	0.0108	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00031	0.01	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000298	0.00965	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000294	0.0095	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—GDNF—Parkinson's disease	0.000279	0.00902	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000275	0.0089	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—GDNF—Parkinson's disease	0.000265	0.00857	CbGpPWpGaD
Flecainide—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000259	0.00839	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000257	0.00831	CbGpPWpGaD
Flecainide—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000242	0.00782	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—DLG1—Parkinson's disease	0.000242	0.00782	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—HSPA8—Parkinson's disease	0.000234	0.00755	CbGpPWpGaD
Flecainide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000226	0.00729	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—DLG4—Parkinson's disease	0.000219	0.00709	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000217	0.00701	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000215	0.00695	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—GRIN2B—Parkinson's disease	0.000214	0.00693	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00021	0.0068	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000209	0.00677	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000208	0.00674	CbGpPWpGaD
Flecainide—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000197	0.00636	CbGpPWpGaD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000191	0.00618	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—GDNF—Parkinson's disease	0.000189	0.00612	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000189	0.0061	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000186	0.006	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000177	0.00572	CbGpPWpGaD
Flecainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000176	0.0057	CbGpPWpGaD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000175	0.00565	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—ABL1—Parkinson's disease	0.000175	0.00565	CbGpPWpGaD
Flecainide—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000174	0.00563	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000172	0.00558	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—HSPA8—Parkinson's disease	0.000167	0.00539	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—HSPA8—Parkinson's disease	0.000158	0.00512	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—DLG4—Parkinson's disease	0.000156	0.00506	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000155	0.00501	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—GRIN2B—Parkinson's disease	0.000153	0.00494	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—DLG4—Parkinson's disease	0.000149	0.0048	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000147	0.00475	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—GRIN2B—Parkinson's disease	0.000145	0.0047	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000143	0.00462	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000142	0.00458	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000125	0.00405	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—ABL1—Parkinson's disease	0.000125	0.00403	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.000124	0.00402	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000124	0.004	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000122	0.00396	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—ABL1—Parkinson's disease	0.000118	0.00383	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000118	0.0038	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000117	0.00377	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—HSPA8—Parkinson's disease	0.000113	0.00365	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000112	0.00361	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000111	0.00358	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—DLG4—Parkinson's disease	0.000106	0.00343	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000105	0.00339	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000105	0.00338	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—GRIN2B—Parkinson's disease	0.000104	0.00335	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—ABL1—Parkinson's disease	8.45e-05	0.00273	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—INS—Parkinson's disease	8.24e-05	0.00266	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	8.23e-05	0.00266	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	8.11e-05	0.00262	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.6e-05	0.00246	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	7.59e-05	0.00245	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	7.53e-05	0.00243	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.49e-05	0.00242	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.42e-05	0.0024	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	6.88e-05	0.00223	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—COMT—Parkinson's disease	6.29e-05	0.00203	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	6.26e-05	0.00202	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	6.25e-05	0.00202	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—COMT—Parkinson's disease	6.24e-05	0.00202	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	6.21e-05	0.00201	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	6.2e-05	0.00201	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	6.19e-05	0.002	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	6.17e-05	0.002	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	6.15e-05	0.00199	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	6.13e-05	0.00198	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	6.12e-05	0.00198	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	5.75e-05	0.00186	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	5.7e-05	0.00184	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	5.67e-05	0.00183	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	5.62e-05	0.00182	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—INS—Parkinson's disease	5.58e-05	0.00181	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—IL6—Parkinson's disease	5.04e-05	0.00163	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TNF—Parkinson's disease	4.46e-05	0.00144	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.29e-05	0.00139	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MCCC1—Parkinson's disease	4.08e-05	0.00132	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ND3—Parkinson's disease	4.08e-05	0.00132	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ND3—Parkinson's disease	4.04e-05	0.00131	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MCCC1—Parkinson's disease	4.04e-05	0.00131	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TALDO1—Parkinson's disease	3.83e-05	0.00124	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—OMD—Parkinson's disease	3.83e-05	0.00124	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TALDO1—Parkinson's disease	3.8e-05	0.00123	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—OMD—Parkinson's disease	3.8e-05	0.00123	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	3.64e-05	0.00118	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	3.6e-05	0.00117	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—IL6—Parkinson's disease	3.6e-05	0.00116	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GCH1—Parkinson's disease	3.47e-05	0.00112	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GCH1—Parkinson's disease	3.44e-05	0.00111	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—IL6—Parkinson's disease	3.42e-05	0.00111	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.1e-05	0.001	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—DBH—Parkinson's disease	3.09e-05	0.001	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GBA—Parkinson's disease	3.09e-05	0.001	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.09e-05	0.001	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—DBH—Parkinson's disease	3.06e-05	0.000991	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GBA—Parkinson's disease	3.06e-05	0.000991	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—FBP1—Parkinson's disease	3.06e-05	0.000991	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TNF—Parkinson's disease	3.02e-05	0.000978	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—IL6—Parkinson's disease	2.44e-05	0.000789	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—DDC—Parkinson's disease	2.27e-05	0.000734	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—DDC—Parkinson's disease	2.25e-05	0.000727	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.14e-05	0.000693	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.12e-05	0.000687	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.1e-05	0.000678	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.93e-05	0.000624	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.91e-05	0.000618	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.91e-05	0.000618	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.89e-05	0.000612	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.8e-05	0.000583	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.41e-05	0.000455	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.39e-05	0.000451	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.38e-05	0.000447	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.3e-05	0.00042	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.29e-05	0.000416	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.28e-05	0.000415	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.27e-05	0.000412	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TH—Parkinson's disease	1.27e-05	0.000409	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TH—Parkinson's disease	1.25e-05	0.000406	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.21e-05	0.000393	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.2e-05	0.000389	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—COMT—Parkinson's disease	1.08e-05	0.000348	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.07e-05	0.000346	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.07e-05	0.000345	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—COMT—Parkinson's disease	1.07e-05	0.000345	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.06e-05	0.000343	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.06e-05	0.000342	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.06e-05	0.000341	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.05e-05	0.000338	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.01e-05	0.000328	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1e-05	0.000325	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTM1—Parkinson's disease	9.84e-06	0.000318	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTM1—Parkinson's disease	9.75e-06	0.000315	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GPX1—Parkinson's disease	9.42e-06	0.000305	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GPX1—Parkinson's disease	9.34e-06	0.000302	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MTHFR—Parkinson's disease	8.69e-06	0.000281	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MTHFR—Parkinson's disease	8.62e-06	0.000279	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APOE—Parkinson's disease	8.09e-06	0.000262	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APOE—Parkinson's disease	8.02e-06	0.000259	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—INS—Parkinson's disease	6.91e-06	0.000224	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—INS—Parkinson's disease	6.86e-06	0.000222	CbGpPWpGaD
